表紙
市場調查報告書
商品編碼
991638

BCG疫苗的全球市場:2020∼2027年

Global BCG Vaccine Market, Size, Share, Opportunities and Forecast, 2020-2027

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

促進BCG疫苗市場成長的主要原因,尤其是開發中國家和低度開發國家的結核盛行率增加,及疫苗研究的領域的技術開發。還有全球,尤其是中國與印度的出生率上升,造成市場大幅度成長。加上,政府的政策提高及全球的疫苗接種計劃的重視,更加促進需求擴大。

BCG疫苗的副作用,預計是在預測期間抑制全球市場成長的重要要素。再加上新興國家的BCG疫苗的供不應求,不久的將來,預計是妨礙市場整體成長的另一個要素。

本報告提供全球BCG疫苗市場相關調查分析,市場概要,市場成長的影響要素,各市場區隔、各地區的市場規模和與前一年同期比較成長,及主要企業等相關分析。

目錄

第1章 全球BCG疫苗市場:調查範圍、手法

  • 調查手法
  • 調查目的、範圍

第2章 全球BCG疫苗市場:市場定義、概要

第3章 全球BCG疫苗市場:摘要整理

  • 市場明細:各產品
  • 市場明細:各人口統計
  • 市場明細:各地區

第4章 全球BCG疫苗市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 影響分析

第5章 全球BCG疫苗市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求
  • 專利趨勢

第6章 全球BCG疫苗市場:COVID-19分析

  • 市場上Covid-19分析
    • COVID-19前的市場情境
    • 目前市場情境
    • COVID-19後或未來情境
  • Covid-19期間中的價格動態
  • 需求與供給的頻譜
  • 大流行期間中的市場相關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 全球BCG疫苗市場:各產品

  • 簡介
  • 市場規模分析及與前一年同期比較成長分析(%):各產品
  • 市場魅力指數:各產品
    • 免疫BCG
    • 治療BCG

第8章 全球BCG疫苗市場:各人口統計

  • 簡介
  • 市場規模分析及與前一年同期比較成長分析(%):各人口統計
  • 市場魅力指數:各人口統計
    • 小兒科(0-18歲)
    • 大人(19-35歲)

第9章 全球BCG疫苗市場:各應用領域

  • 簡介
  • 市場規模分析及與前一年同期比較成長分析(%):各應用領域
  • 市場魅力指數:各應用領域
    • 醫院
    • 診所

第10章 全球BCG疫苗市場:各地區

  • 簡介
    • 市場規模分析及與前一年同期比較成長分析(%):各地區
    • 市場魅力指數:各地區
  • 北美
    • 簡介
    • 主要地區具體動態
    • 市場規模分析及與前一年同期比較成長分析(%):各產品
    • 市場規模分析及與前一年同期比較成長分析(%):各人口統計
    • 市場規模分析及與前一年同期比較成長分析(%):各應用領域
    • 市場規模分析及與前一年同期比較成長分析(%):各國
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第11章 全球BCG疫苗市場:競爭情形

  • 競爭模式
  • 市場定位/佔有率分析
  • 合併和收購分析

第12章 企業簡介

  • Merck & Co.
    • 企業概要
    • 產品系列、說明
    • 主要的焦點
    • 財務概要
  • Sanofi Pasteur
  • Japan BCG Laboratory
  • China National Biotech Group
  • Serum Institute of India Pvt. Ltd
  • InterVax Ltd
  • GREENSIGNAL BIO PHARMA LIMITED (GSBPL)
  • STATENS SERUM INSTITUTE
  • 其他企業

第13章 全球BCG疫苗市場:重要考察

第14章 全球BCG疫苗市場:DataM

  • 附錄
  • 關於本公司、服務
  • 諮詢方式
目錄

Global BCG Vaccine Market Is Segmented By Product Segment By (Immune BCG, Therapy BCG), By Demographics Segment (Pediatrics (0-18 Years), Adults (19-35 Years), By Application Segment (Hospitals, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

The Global BCG Vaccine Market is expected to grow at a CAGR during the forecasting period (2020-2027).

The only vaccine available to combat Tuberculosis is the Bacillus Calmette-Gurin (BCG) vaccine (TB). One dose is recommended for healthy babies near the time of birth in countries with a high incidence of Tuberculosis. However, only infants at high risk are usually immunized in areas where Tuberculosis is rare, while confirmed cases of Tuberculosis are personally screened and administered. It is also possible to immunize individuals who are not afflicted with Tuberculosis and who have not been recently immunized yet are also susceptible to drug-resistant Tuberculosis.

Product: DataM Intelligence Analysis (2019)

Market Dynamics

The major factors propelling the growth of the BCG vaccine market are Increases in tuberculosis prevalence, especially in developing and underdeveloped countries, as well as technical developments in the field of vaccine research. Also, the rising birth rates across the globe, especially in China and India, contribute to the market's significant growth. Also, the rise in government policies and a global emphasis on immunization programs further drive demand growth. It is expected that untapped business opportunities in emerging regions can have multiple market growth prospects.

Increasing prevelance of Tuberculosis in developing and under-developed countries

The increasing prevalence of Tuberculosis across the globe, especially in developing and under-developed countries such as India, China, Africa, will stir the demand for BCG vaccine as it is the only vaccine available for the disease. As per the TB Alert organization, It is estimated that a fifth of the global population is afflicted with latent TB. Of these individuals, one in ten will begin to contract the disorder. And about 10 million individuals develop TB annually, contributing to 1.6 million deaths. Also, as per the Global Tuberculosis Report of 2018, the majority of TB patients (66%) live in one of eight countries: India (27%), China (9%), Indonesia (8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%) or South Africa (3 percent ). This high prevalence in emerging countries drives the market for BCG vaccines during the forecast period.

Side effects of BCG vaccine

The side effects of BCG vaccine among individuals are a key factor expected to curtail the global market's growth over the forecast period. Moreover, the shortage of supply in BCG vaccine in emerging countries is another factor expected to hinder the total market's growth in the near future. As UNICEF administered a shortage of 16.7 million BCG vaccines due to less supply capacity.

COVID-19 Impact Analysis

The outbreak of COVID-19 has negatively impacted the growth of the BCG vaccine market globally. The disruption in the supply chain has majorly impacted the growth of the market amidst the pandemic. The escalated focus on COVID-19 vaccine development has led to de-escalation in BCG vaccines. Therefore, the COVID-19 pandemic has hampered the market value of the BCG Vaccine market in 2020.

BCG Vaccine Market Segment Analysis

Based on the product, the BCG vaccine market has been classified into Immune BCG and Therapy BCG

Immune BCG segment is projected to be the dominated segment in the market during the forecast period.

Immune BCG dominated the global market in 2019. Also, the Immune BCG is expected to present considerable growth in the near future. BCG Vaccine is administered to new borns in the risk zone areas with a single dose of Immune BCG to prevent TB development. Therefore, the increasing usage of Immune BCG in the prevention of the development of TB is expected to propel segmental growth in the near future.

BCG Vaccine is segmented on the basis of Demographics, which includes Pediatrics (0-18 Years), Adults (19-35 Years).

Pediatrics (0-18 Years) is expected to dominate the BCG Vaccine market.

Pediatrics (0-18 Years) held the dominant position in the global market during the forecast period. In countries where the BCG vaccine is part of the national childhood immunization policy, BCG is normally offered to all children up to one year of age. In addition, older children (over 1 year of age) who have an elevated chance of contracting Tuberculosis should also be given this vaccine. It is rarely administered above 16 years of age and is never administered above 35 years of age, since vaccines are only successful when administered at an early stage of life.  This is supporting the segment growth during the forecast period.

Product: DataM Intelligence Analysis (2019)

BCG Vaccine is segmented on the basis of Application, which includes Hospitals, Clinics, Others

Hospitals is expected to dominate the BCG Vaccine market.

Hospitals held the dominant position in the global market during the forecast period. The administration of BCG vaccines done after the birth of baby in the hospitals supports the segment growth during the forecast period. Moreover, the Clinics is expected to project a considerable CAGR during the forecast period. Older children (more than 1 year of age) who have an elevated risk of contracting Tuberculosis may also receive this vaccine administered at Clinics.

BCG Vaccine Market Geographical Analysis

Based on geography, the study analyzes the BCG vaccine market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Asia Pacific is expected to dominate the global BCG Vaccine market

Asia Pacific held a dominant position in the global BCG vaccine market in 2019. In Asia, the India is expected to represent considerable growth during the forecast period. In India, the prevalence of TB was 27% of the total in 2018. Moreover, Middle East and Africa are expected to represent significant growth in value during the forecast period. BCG Vaccine market for Asia Pacific is expected to observe rapid growth over the forecast period, backed by the growth of the tuberculosis cases in the region coupled with increasing government initiatives to combat the disease.

Competitive Landscape

The BCG vaccine market is highly competitive, owing to the presence of major developments in vaccine production. The key BCG Vaccine players which are contributing to the growth of the global market include Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotech Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institute among others. The major players are adopting new product launch and expansion strategies for global growth in the BCG Vaccine market.  

TICE® BCG (Merk & Co. Inc.):

TICE® BCG is an attenuated live culture preparation for intravesical use of the Mycobacterium bovis strain Bacillus of Calmette and Guerin (BCG).1 The TICE strain was developed from a strain originating at the Pasteur Institute at the University of Illinois.  At the local site of administration, TICE® BCG causes a granulomatous reaction. Intra-vesical. TICE BCG has been used as a treatment for recurring tumors and prophylaxis against them in Patients of urinary bladder carcinoma in situ (CIS) and to avoid recurrence of Stage III TaT1 papillary bladder tumors are at high risk for recurrence.

Product Portfolio: The Company's portfolio comprises Vaccines, Medications and medical devices among others

Why Purchase the Report?

Visualize the BCG Vaccine market segmentation composition by product, demographics, application and Region, highlighting the critical commercial assets and players.

Identify commercial opportunities in the BCG Vaccine market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of BCG vaccine market - level 3 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global BCG Vaccine market report would provide access to an approx. 51 market data table, 45 figures and 221 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Suggestions for Related Market Report:

Global Tuberculosis Market

Global Vaccine market

Table of Contents

Table of Contents

BCG Vaccine Market Methodology and Scope

Research Methodology

Research Objective and Scope of the Report

BCG Vaccine Market - Market Definition and Overview

BCG Vaccine Market - Executive Summary

Market Snippet by Product

Market Snippet by Demographics

Market Snippet by Application

Market Snippet by Region

BCG Vaccine Market - Market Dynamics

Market Impacting Factors

Drivers

Increasing Prevalence of Tuberculosis in Developing and under-developed countries

Increasing birth rates across the globe

Restraints:

Side effects of BCG vaccine

Impact Analysis

BCG Vaccine Market - Industry Analysis

Porter's Five Forces Analysis

Supply Chain Analysis

Value Chain Analysis

PEST Analysis

Pricing Analysis

Regulatory Analysis

Reimbursement Analysis

Unmet Needs

Patent Trends

BCG Vaccine Market - COVID-19 Analysis

Analysis of Covid-19 on the Market

Before COVID-19 Market Scenario

Present COVID-19 Market Scenario

After COVID-19 or Future Scenario

Pricing Dynamics Amid Covid-19

Demand-Supply Spectrum

Government Initiatives Related to the Market During Pandemic

Manufacturers Strategic Initiatives

Conclusion 

BCG Vaccine Market - By Product

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment

Market Attractiveness Index, By Product Segment

Immune BCG*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Therapy BCG

BCG Vaccine Market - By Demographics

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics Segment

Market Attractiveness Index, By Demographics Segment

Pediatrics (0-18 Years)*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Adults (19-35 Years)

BCG Vaccine Market - By Application

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment

Market Attractiveness Index, By Application Segment

Hospitals*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Clinics

BCG Vaccine Market - By Region

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

Market Attractiveness Index, By Region

North America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

U.S.

Canada

Mexico

Europe

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Germany

U.K.

France

Italy

Spain

Rest of Europe

South America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Brazil

Argentina

Rest of South America

Asia Pacific

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

China

India

Japan

Australia

Rest of Asia Pacific

Middle East and Africa

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Demographics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

BCG Vaccine Market - Competitive Landscape

Competitive Scenario

Market Positioning/Share Analysis

Mergers and Acquisitions Analysis

BCG Vaccine Market- Company Profiles

Merck & Co.*

Company Overview

Product Portfolio and Description

Key Highlights

Financial Overview

Sanofi Pasteur

Japan BCG Laboratory

China National Biotech Group

Serum Institute of India Pvt. Ltd

InterVax Ltd

GREENSIGNAL BIO PHARMA LIMITED (GSBPL)

STATENS SERUM INSTITUTE

Other companies (List Not Exhaustive)

BCG Vaccine Market - Premium Insights

BCG Vaccine Market - DataM Intelligence Analysis

Appendix

About Us and Services

Contact Us